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Abstract
Biologically active natural products often contain particularly challenging structural features and
functionalities. Perhaps foremost among these difficulties are issues of stereochemistry. A useful
strategy for synthesizing these molecules is to devise novel methods of bond-formation that provide
new opportunities for enantioselective catalysis. In using this tactic, target structures define the
problems to be solved and ultimately drive development of catalysis forward. New enantioselective
methods discovered in the context of these total synthesis efforts then contribute to a greater
understanding of fundamental bond construction and lead to valuable synthetic technologies useful
for a variety of other applications.
Inasmuch as retrosynthetic analysis1 enables synthetic planning toward valuable chemical
substances, one can be easily discouraged by a lack of methods to install particular
functionalities or structural motifs present in the target molecule. Still more difficult is adapting
a strategic approach to incorporate the relatively limited number of catalytic enantioselective
transformations to allow preparation of enantioenriched materials for further studies.2,3,4,5,
6 However, when encountering the structural challenges presented by important natural
products and pharmaceutical compounds a fruitful strategy is to design a synthesis that hinges
upon a particular bond disconnection that is beyond the present lexicon of enantioselective
transformations. Employing this strategy, the structures of target molecules provide the impetus
for the development of novel transformations and lead to a greater fundamental understanding
of methods of bond construction and catalysis. In this Review several recent examples of novel
catalytic enantioselective transformations demonstrate the effectiveness of this useful strategy
for the preparation of important structural motifs found in biologically active molecules. Each
example has contributed not only an effective means of accessing a particular target structure,
but also a useful new tool for a variety of further applications in synthetic chemistry.
To provide an overview of established catalytic enantioselective methods developed in the
context of total synthesis, several notable examples are highlighted in Figure 1. In each of these
cases, the target molecules posed particular challenges that had not yet been solved by
enantioselective catalysis. Although in some instances (e.g., Diels–Alder reaction, Figure 1a)
the methods were developed before their first applications in total synthesis, but the
demonstrated value of the transformation served to further highlight the need for
enantioselective variants. Subsequent to the development of the [4 + 2] cycloaddition by Diels
and Alder in the 1920s,7 many studies of this transformation elucidated several key facets of
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the stereochemical outcome of the reaction (e.g., the “endo rule”, regioselectivity, and
diastereoselectivity). These intrinsic stereochemical control elements proved useful when the
Diels–Alder reaction was first featured in a total synthesis with Stork's stereocontrolled
synthesis of cantharidin in 1951.8 Subsequently, the thermal Diels–Alder reaction found
application in several total syntheses, perhaps most famously in Woodward's landmark
synthesis of reserpine.9 Enantioselectivity in this transformation remained elusive, however,
and perhaps was considered unattainable. One key practical improvement of the method was
Yates' discovery that Lewis acids remarkably increased the reaction rate.10 Many laboratories
sought to exploit Yates' discovery to develop asymmetric versions of the Diels–Alder reaction
catalyzed by chiral Lewis acids, culminating with Koga's report of the first highly
enantioselective catalytic Diels–Alder reaction in 1979.11 The interface between reaction
development, mechanistic study, and synthesis is readily apparent from the multitude of chiral
Diels–Alder catalysts and accompanying enantioselective total syntheses reported to date.12,
13,14 These successes validate the extensive efforts directed toward the realization of this
important goal.
Other methods were developed to address more general synthetic problems (e.g.,
enantioselective ketone reduction, Figure 1a), however, these key structures are themselves
embedded in a variety of important natural products and pharmaceutical compounds. In the
case of Corey's approach to the prostaglandins, first reported in the 1960s,15 control of the
configuration of the sidechain allylic alcohol at C(15) required stoichiometric chiral reducing
agents until a solution to this long-standing problem was disclosed in the 1980s.16
Interestingly, the oxazaborolidine catalyst discovered in these explorations has found other
varied applications in synthesis and catalysis13,17 demonstrating the versatility of priveledged
molecular frameworks18 in enantioselective catalysis.
The practical impact of enantioselective catalysis is apparent in myriad industrial applications
(e.g., Figure 1b–d) where the limits of catalysis must be examined in order to minimize costs.
Important industrial applications include synthesis of chiral building blocks (e.g., amino acids,
Figure 1b19), novel biologically active pharmaceuticals (e.g., Crixivan®, Figure 1c20), and
commodity chemicals with various important uses (e.g., menthol, Figure 1d21). Only the most
efficient methods are feasible for large-scale industrial synthesis and in many ways these
protocols represent the zenith of modern enantioselective catalysis.22,23,24 A viable
commercial operation must account for more than effective asymmetric induction; factors
including turnover frequency, catalyst availability, catalyst recovery, catalyst toxicity, and
feasible large-scale handling procedures must all be considered for industrial applications.
These daunting challenges serve to further underscore the persisting demand for evermore
efficient catalyst systems.
To maximize the utility of the stereochemistry imparted by these key asymmetric
transformations, subsequent diastereoselective reactions may be used in order to control the
formation of many stereocenters based on a single enantioselective transformation (e.g., Figure
1e). The Hajos–Parrish ketone, first prepared in the context of steroid synthesis, has been used
extensively in other synthetic efforts, proving to be a versatile chiral pool starting material
based on a variety of diastereoselective transformations developed around this versatile
bicyclic platform.25,26,27 Interestingly, the amino acid catalyst system developed for this
intramolecular aldol condensation provided a sound basis for the recent use of organic
molecules as catalysts for a variety of enantioselective transformations (vide infra).
The use of several different enantioselective reactions to prepare enantioenriched fragments
of complex molecules enhances efficiency through convergency. The importance of this
strategy is shown in the variety of extraordinarily complex polyketide natural products that
have been prepared through asymmetric intermolecular aldol reactions (e.g. phorboxazole B,
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Figure 1f28). The challenging structure of these molecules has required the development of
several related protocols to address the subtle differences in substitution patterns and
functionality present in substrates, and despite many successes, studies are ongoing.29 Indeed,
polyketide natural products exemplify the continuing need for reaction development in order
to address stereochemically complex substructures.
The remaining examples in this Review detail recent representative developments of this
paradigm for the construction of biologically important target molecules. Most of these involve
the formation of C–C bonds, which compose the fundamental structure of organic molecules.
These cases were selected to illustrate some of the latest developments in enantioselective
catalysis for complex molecule synthesis. Special attention has been given to reactions that
address some of the most significant challenges to synthetic chemistry today: increasing
functional group tolerance, generating new carbocylic- and heterocyclic-rings, and forming
all-carbon quaternary stereocenters. The examples are intended to demonstrate the important
symbiosis between total synthesis and method development and to show that improvements
in one branch of synthetic chemistry can have a great impact in another.
β-Enamino Amide Hydrogenations – Januvia®
Throughout more than forty years of development, catalytic enantioselective hydrogenation
has become one of the most effective and powerful methods for the synthesis of chiral α-amino
acids for numerous applications.19 Over the past decade, the utility of their homologous
building blocks, β-amino acids, in pharmaceutical, agrochemical, β-peptide, and natural
substances has highlighted the need for a general and effective means of their preparation.30,
31 Undoubtedly, the implementation of a catalytic, asymmetric hydrogenation N-acyl-β-
enamino esters seemed to be the most efficient pathway toward their synthesis, although initial
investigations realized poor selectivities.32 Additional syntheses utilizing the chiral pool,
auxiliaries, and more recently the catalytic, asymmetric generation of C–C and C–N bonds,
have been successful in satisfying the increased demand for β-amino acids.31 These valuable
methods enable flexible strategies for the synthesis of a variety of analogues; however, most
examples are limited by the requirement that further chemical manipulation is often necessary
to reveal the functionality of the desired β-amino acids.
Despite initial difficulties, the asymmetric hydrogenation of N-acyl-β-enamino esters has been
developed into a useful method over the past 15 years.33,34 This fruitful endeavour has
demonstrated that a number of transition metal and ligand combinations are competent for the
preparation of N-acyl-β-amino acids with good to excellent enantioselectivities. A notable
drawback to this strategy, however, is the requirement of the seemingly indispensable N-acyl
group on the β-enamino esters, which enables metal chelation to improve reactivity and
selectivity. The introduction of this moiety often produces enamine olefin isomers that can be
difficult to separate, and importantly, the individual isomers are typically hydrogenated with
differing rates and selectivities. Moreover, these difficulties were magnified by the necessary
removal of this group, a seemingly cumbersome artifact of an otherwise powerful strategy.
Nonetheless, this has enabled the preparation of a variety of β-amino acids.31
An innovative solution to this problem was demonstrated by a Merck group en route to
Januvia® (sitagliptin phosphate, 8, Figure 2), a recent FDA-approved treatment for type II
diabetes mellitus.35 The optimal target contains an unfunctionalized β-amino amide, and thus
a strategy was sought to install this moiety directly by means of an asymmetric hydrogenation
of unsubstituted β-enamino ester and amide derivatives (e.g., 4).36 A traditional hydrogenation
route to amino acids is a proven, cost-effective method for the synthesis of chiral building
blocks, and the industrial infrastructure is already in place to realize this goal, however,
reduction of unprotected β-enamino acids was not effective with existing chiral catalysts. A
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critical element to address such limitations is Merck's high-throughput screening facility, a
platform technology to rapidly screen catalyst structures and reaction conditions, an essential
component for the success of any catalytic, asymmetric process.37 One potential complication
for this hydrogenation strategy was avoided when it was observed that the preparation of the
β-enamino ester and amide (e.g., 3 → 4) substrates proceeded with complete selectivity for the
(Z)-isomer, presumably due to hydrogen bonding in the products.
A survey of transition metals and ligands revealed that rhodium complexes of the Josiphos
(e.g., 5) family of ligands efficiently catalyze the hydrogenation of a variety of substrates in
high yields with excellent enantioselectivities. The remarkable functional group tolerance of
this catalyst enabled the strategic implementation of this asymmetric transformation as the
penultimate step of the synthesis, thereby maximizing the utility of the process and materials.
Thus, phenylacetic acid derivative 1 was converted into β-ketoamide 3 in a one pot procedure
via acylation of Meldrum's acid, followed by treatment with triazole salt 2 (Figure 2).38
Exposure to ammonium acetate converted this into β-enamino amide 4 as a single enamine
isomer. Hydrogenation of 4 in the presence of 0.30 mol% of rhodium(I) and ligand 5 provided
β-amino amide 7 in >95% conversion and 95% enantiomeric excess (ee). Subsequent
recrystallization and salt formation with phosphoric acid gave Januvia® (sitagliptin phosphate,
8). Efforts to optimize efficiency and examine the mechanism of the asymmetric process
revealed a reactivity and selectivity dependence on the pH of the reaction solution.39 It was
found that ∼1 mol% of a mild acid (i.e., ammonium chloride) was essential for the reaction to
proceed reproducibly on large scale. Additionally, it was observed that hydrogenation of a
related substrate under identical conditions with a D2 atmosphere resulted in deuterium
incorporation at the β-position only, suggesting the intermediacy of an imine (i.e., 7) and that
an enamine/imine tautomerization process plays an important role in the mechanism.36
Interestingly, intermediates such as 7 share a striking similarity to asymmetric β-carbonyl
hydrogenations pioneered by Noyori.40
This example demonstrates the evolution of asymmetric catalysis to a state of the art science
through efficiency by minimization of unnecessary functionality, atom economy, and
extremely active catalysts. Moreover, the development of the catalyst system for the synthesis
of Januvia® exemplifies the continued need for subtly different catalysts to meet new synthetic
demands. Building on the experience attained during the development of highly efficient
enamide reduction toward α-amino acids, large-scale industrial synthesis of increasingly
important β-amino acids has been a relatively rapid process.
C(sp3)–C(sp3) Cross-Couplings – Fluvirucinine A1
Transition metal-catalyzed cross-coupling reactions have been used extensively for the
construction of C–C bonds, and consequently have had a substantial impact on the field of
complex molecule synthesis.41,42 The predominance of palladium and nickel catalysts in
cross-coupling technologies and their extraordinary functional group tolerance increases the
efficiency of this process through convergency by allowing a large degree of functionalization
prior to coupling. Moreover, the efficacy of this cross-coupling strategy for streamlining
synthesis has enabled retrosynthetic analyses previously thought impossible with standard,
non-metal reactions. Until recently, however, the majority of cross-coupling methods involved
C(sp2)–C(sp2) or C(sp2)–C(sp) centers, limiting the application potential. Two critical issues
associated with expanding the substrate scope to include C(sp3)–C(sp3) couplings are the
relative low reactivity of alkyl halides toward oxidative addition, and the propensity of σ-alkyl
organometallic complexes to undergo rapid β-H elimination reactions.43,44 Practical solutions
to this problem were first presented by Suzuki and Knochel, followed more recently by Fu and
others.44,45 In general, the reaction scope now encompasses a variety of primary and
secondary halides and pseudohalides as the electrophilic component with organoboranes,
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boronic acids, alkylmagnesium halides, and alkylzinc halides as the nucleophilic component.
44 Although perhaps not developed in the context of a particular target molecule, progress in
these cross-coupling methods has allowed retrosynthetic disconnections that were not practical
previously. Asymmetric cross-coupling protocols could in turn enable the direct formation of
remote stereocenters in relatively unfunctionalized molecules.
Early examples of catalytic, asymmetric cross-coupling reactions involving C(sp3)–C(sp2)
centers explored by Kumada and coworkers in the late 1970's were met with modest
enantioselectivities.46,47 Despite these initial reports and the subsequent evolution of cross-
coupling methods and asymmetric catalysis, a deficiency in the development of catalytic,
asymmetric methods for C(sp3)–C(sp3) couplings existed until Fu and coworkers reported an
asymmetric Negishi coupling in 2005.48,49 Prior to this report, the Fu lab observed the
proficiency of tridentate pybox ligands (e.g., 16, Figure 3) to enable the room-temperature,
nickel-catalyzed Negishi coupling of symmetrical secondary alkyl bromides and iodides.50 It
was postulated that the tridentate nature of pybox ligands prevented the undesired β-H
elimination pathway, which would require a vacant coordination site. Reaction optimization
facilitated the development of several asymmetric variations that generate challenging
stereocenters applicable to complex molecule synthesis, as demonstrated in Fu's formal total
synthesis of fluvirucinine A1 (17), the aglycon of macrolactam antibiotic fluvirucin A1 (18).
51 A key nickel(II)-catalyzed asymmetric cross-coupling of racemic allylic chloride 9 and
alkylzinc reagent 10 in the presence of (S,S)-16 generated γ-disubstituted enone 11 in excellent
yield and 96% ee. Elaboration over two steps to bromide 12, followed by conversion to the
alkylzinc and a second nickel(II)-catalyzed asymmetric Negishi cross-coupling with racemic
allylic chloride 13, provided ester 14 in good yield and >98% ee with a 15:1 diastereomer ratio
(d.r.) A subsequent two-step conversion to aldehyde 15 intersects Suh's52 synthesis of
fluvirucinine A1 (17). This method exemplifies the efficiency of the C(sp3)–C(sp3) cross-
coupling and presents a creative solution to the particularly difficult challenge of remote
stereochemical control.
At present, the majority of examples of this technology require a stabilizing group adjacent to
the site of the putative carbon-centered radical. Eliminating this condition would further
improve the utility of this asymmetric cross-coupling method. Additionally, stereogenic
organometallic coupling partners (e.g., secondary alkylzinc reagents) have not yet been
reported in this asymmetric transformation. A potential goal for this synthetic method would
be combination of a racemic secondary alkyl halide and a racemic secondary alkylmetal reagent
to form vicinal stereocenters along an alkyl chain with high levels of enantio- and
diastereoselectivity.
Intramolecular Heck Cyclizations – Minfiensene
The asymmetric generation of all-carbon quaternary stereocenters represents a significant
challenge in synthesis.53 Since quaternary stereocenters are found in many natural product
structures, convenient enantioselective methods for their formation would be useful. One such
method is the Heck reaction,54 wherein a palladium(0) catalyst promotes the vinylation of an
aryl or vinyl halide or triflate. The large body of literature on palladium catalysis and
mechanism,41 as well as an ever-growing collection of chiral ligands for transition-metal
catalysis, greatly increased the potential of this method toward asymmetric catalysis.
Additionally, an abundance of synthetic endeavors employing diastereoselective or non-
stereoselective intramolecular Heck reactions have appeared,55 increasing the significance of
an enantioselective process. In 1989, the labs of Shibasaki56 and Overman57 independently
reported the first variants of an intramolecular catalytic, asymmetric Heck reaction. Initial
levels of enantioselectivity were moderate; however, subsequent optimizations realized good
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to excellent selectivities in the generation of tertiary and all-carbon quaternary stereocenters.
58
Indole alkaloids comprise a large number of natural and pharmaceutical substances that possess
a wide range of biological activities.59 The plant alkaloid minfiensine (22, Figure 4) represents
a compelling example of the all-carbon quaternary stereocenter motif in bioactive natural
products. Minfiensine and related alkaloids have been used in traditional medicines and possess
promising anticancer activity.60 The intriguing polycyclic structure and biological relevance
of minfiensine (22) prompted the Overman laboratory to explore a catalytic, enantioselective
Heck reaction to generate the sole quaternary stereocenter at C(9a).61 It was discovered that
the palladium-catalyzed intramolecular Heck reaction of dienyl aryl triflate 19 in the presence
of phosphinooxazoline ligand (S)-23 under microwave conditions produced indoline 20 in good
yield 99% ee. Subsequent acid promoted carbamate cyclization produced the tricyclic core of
minfiensine (i.e., 21) that was then elaborated to the natural product. The efficiency and
selectivity of the catalytic, asymmetric Heck reaction facilitated completion of the target, where
the remaining stereocenters are derived from this initial transformation.
Despite numerous examples of the asymmetric Heck reaction in total synthesis,58 there are
several features that could be improved in the coming years. Reactions typically require high
temperatures and somewhat high catalyst loadings, and the development of chiral ligands that
greatly increase the reactivity of the transition metal while maintaining an adequate asymmetric
environment would be greatly beneficial. Since most enantioselective Heck reactions employ
an sp2-hybridized organohalide component, another frontier lies in the application of
unactivated alkyl carbon electrophiles that possess β-hydrogens in both intramolecular and
intermolecular cases, and area currently in its infancy.62
Indole Friedel–Crafts Alkylations – Flustramine B
Numerous methods have been developed for the generation of substituted indoles,63,64
however, enantioselective indole functionalization is far less explored. To address the
deficiencies in the indole functionalization literature, Jørgensen65 and MacMillan66
independently developed strategies for asymmetric Friedel–Crafts alkylation of conjugate
acceptors with electron-rich heteroaromatics in 2001. The method of MacMillan employs
secondary amine catalyst 28 (Figure 5) that facilitates the LUMO-lowering activation of α,β-
unsaturated aldehydes for a variety of transformations.67,68 Although imidazolidinone 28 was
a sufficient catalyst for the Friedel–Crafts alkylation of pyrroles with good yields and excellent
enantioselectivities,66 application of less-activated indole substrates resulted in sluggish
reactivity with considerably diminished selectivities.69 Kinetic investigations of iminium-
catalyzed reactions revealed that the overall reaction rate was influenced by the efficiency of
formation for both the iminium ion and C–C bond, prompting the development of a modified
imidazolidinone catalyst (29). This refinement minimized the steric bulk around one face of
the catalyst, thereby exposing the nitrogen lone-pair. This structural change translated into
increased reactivity that enabled the asymmetric Friedel–Crafts alkylation of a variety of
indoles in good to excellent yields with very high enantioselectivities.69
Pyrroloindoline alkaloids represent a family of polyindole alkaloids of diverse structural
complexity and biological relevance.70 Diastereoselective syntheses of this core have focused
on the control of the C(3a) all-carbon quaternary stereocenter as a key design element.71,72,
73 With a powerful and mild indole alkylation method in hand, MacMillan and coworkers
devised a cascade strategy for the catalytic, asymmetric preparation of the C(3a) stereocenter
and the pyrroloindoline core of potassium-channel blocker (−)-flustramine B (27) in one step.
74 In this key transformation, tryptamine derivative 24 and acrolein, in the presence of catalyst
29, underwent the asymmetric Friedel–Crafts alkylation to provide iminium intermediate 25.
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Subsequent carbamate cyclization and hydrolysis to regenerate the catalyst provided the core
(26) in good yield and 90% ee. Importantly, this enabled completion of (−)-flustramine B
(27) in just 6 steps and good overall yield and highlights the efficiency of this cascade approach.
It is noteworthy that this strategy is not reserved for the pyrroloindoline architecture, but also
has potential for application to various polycyclic indolines such as the diazonamide family of
cytotoxic alkaloids.74 It is interesting to note the capacity of both the intramolecular Heck
reaction (vide supra) and indole Friedel–Crafts alkylation to generate similar indoline structural
motifs despite the drastically different bond-connecting strategies. The success of these
dissimilar strategies allows for a great deal of flexibility in synthetic planning.
Although iminium activation methods with chiral amine catalysts have been successful for
numerous transformations, catalyst loading, turnover frequency, and excesses of certain
reagents limit the large-scale industrial application of these methods. Additionally, in some
cases the organic catalyst may be more difficult to remove from the reaction products than a
metal catalyst. However, the typically air- and moisture-stable reaction conditions, low cost of
some catalysts, and often metal-free conditions are attractive. The variety of asymmetric
transformations (some proceeding through substantially different reaction pathways) realized
with chiral amine catalysts to date indicates a burgeoning field of useful enantioselective
catalysts.
Pictet–Spengler Cyclizations – Harmicine
Since the intramolecular cyclization of an aromatic ring onto an iminium species was reported
by Pictet and Spengler in 1911,75 the transformation has been of great use in the synthesis of
many important alkaloid natural products.76 Indeed, the need for asymmetric variants of this
reaction was recognized and several diastereoselective protocols have been devised.76 A
common approach to diastereoselective Pictet–Spengler cyclization has been to employ
tryptophan derivatives to control the stereochemistry of the cyclization. However, such a
technique in the synthesis of a natural product such as the anti-leishmania compound harmicine
(35, Figure 6) necessitates the removal of the stereocontrol element at C(5) following the
diastereoselective cyclization. Nonetheless, Allin and coworkers proved this a method viable
method in 2007.77 This particular structure, however, highlighted a challenge for
enantioselective catalysis and an opportunity to improve synthetic efficiency.
When considering prospects for asymmetric induction, Jacobsen and Taylor considered
activated N-acyliminium ions as a template and reasoned that a chiral thiourea derivative might
be effective in promoting cyclization. In practice these Brønsted acids,78 as well as other
Brønsted acids investigated later by other groups,79,80 proved to be excellent catalysts for
enantioselective indole annulations with in situ generated N-acyliminium species (e.g., 33). In
later studies by Jacobsen and coworkers it was found that hydroxylactams (e.g., 31) are
convenient precursors to N-acyliminium ions and in turn enabled access to various polycyclic
structures.81,82 With this effective protocol in hand, an efficient catalytic asymmetric
synthesis of harmicine (35) was realized in four steps from tryptamine (30). Several
mechanistic experiments have suggested that asymmetric induction is controlled by a complex
of the Brønsted acid catalyst (32) and a chloride counterion closely associated with the iminium
ion (e.g., 33) that effectively blocks approach to one face of the electrophile. This insight into
the remarkable mechanism of this transformation has led to a related C–C bond forming process
employing oxocarbenium ions.83 Further exploitation of this unusual proposed catalyst/anion
interaction could lead to a variety of other asymmetric addition reactions, for example,
intermolecular alkylation N-acyl iminium ions. Paralleling the history of the Diels–Alder
reaction (vide supra), the exploration of the Pictet–Spengler cyclization has provided a useful
method to access many heterocyclic structures embedded in alkaloid natural products using a
classical reaction with well-established synthetic applications.
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Phase Transfer Alkylations – Indacrinone
Enolate alkylations exemplify the fundamental utility of the carbonyl group for C–C bond
formation. Strategies to induce asymmetry in these reactions have included chiral auxiliaries
and chiral ligands, although few examples are catalytic. A particularly challenging class of
product targets are all-carbon quaternary stereocenters adjacent to carbonyl groups. One
example of an important target bearing this motif is the diuretic drug candidate indacrinone
(40, Figure 7).84 Given the lack of efficient methods for synthesizing this structure, researchers
at Merck envisioned an enantioselective phase transfer alkylation method based on a quaternary
ammonium salt derived from a naturally occurring cinchona alkaloid (e.g., 37). In the event,
readily prepared indanone 36 was methylated in 95% yield and 92% ee and then converted to
indacrinone (40) in three additional steps. Although successful in achieving enantioselective
enolate alkylation, the mechanism of this process appears to be very complicated;85 however,
enantiofacial selectivity in the alkylation event may be rationalized through hypothetical
transition state 38. Three key interactions are thought to control selectivity: a hydrogen bond
between the enolate oxygen and the catalyst hydroxyl group, and two π-stacking interactions
between the four aromatic rings. Perhaps a consequence of the complex mechanism, the
substrate scope for enolate alkylation is unfortunately limited and other solutions to this
problem are still necessary. However, these initial results have led to several related catalytic
enantioselective reactions employing cinchoninium salts or related organic ammonium
complexes as catalysts.86 The discovery of these useful catalysts has provided not only an
alternative to related transformations using metal catalysts, but also a means of accessing chiral
environments that are simply not possible with metal-based catalysts. Moreover, eliminating
metal waste materials is attractive from an industrial and environmental standpoint. Ultimately,
the studies directed toward an enantioselective synthesis of indacrinone (40) demonstrate the
versatility of privileged catalysts developed for the synthesis of target molecules for a range
of other applications.
Pd-Catalyzed Enolate Alkylation – Cyanthiwigin F
A recent case of enantioselective enolate alkylation is the synthesis of the cytotoxic marine
natural product cyanthiwigin F (48, Figure 8). The cyanthiwigin family is composed of over
thirty diterpenoids, most of which bear two quaternary stereocenters, at C(6) and C(9), and a
syn-relationship of the methyl groups in the central ring. These central stereochemical elements
are a complicating factor for a convergent strategy that might seek to couple the five- and
seven-membered ring portions and subsequently form the six-membered ring. To avoid this
difficulty, Enquist and Stoltz chose instead to address these two central stereocenters at an
early stage and append the five- and seven-membered rings to the assembled cyclohexane.
Accordingly, a synthetic strategy was devised that involved a one-pot, double-enantioselective
enolate alkylation reaction to simultaneously form both quaternary stereocenters. Although
such enantioselective alkylations have proven difficult, recent research in the Stoltz
laboratories and others had identified palladium-catalysts that may provide a solution to this
problem and enable the synthesis of a variety of targets containing quaternary carbon
stereocenters, including the cyanthiwigins.87,88
The implementation of this plan began with a Claisen–Dieckmann sequence that converted
diallyl succinate (41) to bis(β-ketoester) 42 as a 1:1 mixture of racemic and meso diastereomers.
Upon exposure to the catalyst derived from Pd(dmdba)2 and phosphinooxazoline ligand
(S)-23,89,90 were transformed to bis(allylated) ketone 43 in 75% yield and 99% ee as a 4.4:1
mixture of diastereomers. With both quaternary centers in place, elaboration of this
stereochemically rich core structure to the natural product was achieved in six further steps.
Enol triflate formation and Negishi coupling preceded a tandem ring-closing metathesis/cross-
metathesis sequence with Grubbs' ruthenium catalyst 45. Aldehyde-olefin radical cyclization
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generated the final ring of the cyanthiwigin core (i.e., 47), and enol triflate formation and
palladium-catalyzed cross-coupling formed (−)-cyanthiwigin F (48). Choosing to confront the
difficult stereochemical elements of the cyanthiwigin structure at an early stage led to a direct
synthetic route proceeding in nine steps from diallyl succinate (41). The strategy herein was
enabled by the intriguing reaction mechanism of the enantioselective decarboxylative
allylation, in which all three stereoisomers of bis(β-ketoester) 42 are selectively converted to
a particular stereoisomer of product (43) with high selectivity through a stereoablative process.
91 Additionally, of the nine steps required for the synthesis, seven form C–C bonds, and four
of these steps form multiple C–C bonds. Directly addressing the carbon-framework of the target
molecule and the stereochemical challenges embedded within ultimately lead to an efficient
synthetic sequence to this important molecule.
At this time, the proposed chiral palladium enolate has been intercepted by allyl or proton
electrophiles.89 Although the synthesis of cyanthiwigin F (48) demonstrates the versatility of
allyl moieties for further derivatization, the direct use of alternative electrophiles would provide
a more general and direct method for transition metal-mediated enolate functionalization.
Trimethylenemethane Cyclizations – Marcfortine B
Of the many fundamental approaches to the formation of five-membered rings from acyclic
precursors, the [3 + 2] cycloaddition is among the most convergent strategies. A useful method
of achieving such a cyclization is via a trimethylenemethane (TMM) intermediate.92 This
interesting non-Kekulé molecule was first prepared and studied by Dowd and coworkers
through photolytic decomposition of a cyclic diazene precursor. However, the free diyl is prone
to several undesired reaction pathways and does not lend itself to asymmetric catalysis. Despite
this, intramolecular diyl trapping reactions are valuable methods of cyclopentane formation.
92 Recognizing the synthetic utility of TMM, Trost and coworkers developed an array of 2-
(trimethylsilyl)-2-propenyl acetate reagents that generate a metal•TMM complex when
exposed to a palladium catalyst.93,94 A recent application of this transformation in total
synthesis is the approach to marcfortine B (55, Figure 9a), a member of a family of anti-parasitic
agents, by Trost and coworkers.95 The strategy employed sought to forge the [2.2.2]bicycle
via an intramolecular radical cyclization, and install the spiro all-carbon quaternary
stereocenter by the cycloaddition of oxindole 50 with TMM precursor 51. In the event, an
excellent yield was observed for the annulation reaction yielding spirooxindole 52 as a 1:1
mixture of diastereomers. Over the course of nine additional steps, spirocycle 52 was
transformed into amide 53. Preparation of the xanthate derivative of alcohol 53 enabled radical
cyclization generating the challenging [2.2.2]bicycle 54. Seven further steps produced (±)-
marcfortine B (55).
Although this strategy demonstrated several intriguing ring-forming reactions, an asymmetric
synthesis of 55 would require an enantioselective variant of the key TMM-[3 + 2]
cycloaddition, a goal that has remained elusive.96 Ito and coworkers reported the first
asymmetric [3 + 2] cycloaddition with various bis(phosphine) ligands, but observed only
moderate enantiomeric excess (up to 78%) and diastereomeric ratio (up to 4:1 trans:cis).97
Thereafter, Trost and coworkers explored bulky monodentate phosphoramidite ligands (e.g.,
(R,R,R)-59) for the transformation and observed very high enantioselectivity for the first time
(Figure 9b).98,99,100 Of particular interest is the enantioselective addition of substituted TMM
reagents to functionalized oxindole derivatives.99 The use of oxindole 56 and TMM-precursor
57 in the palladium-catalyzed cyclization with ligand (R,R,R)-59 yielded spirooxindole 58 with
14:1 d.r. and 96% enantiomeric excess for the major diastereomer. Although a completed
asymmetric synthesis of marcfortine B (55) from intermediate 58 has not been reported, many
of the key functional groups are in place and the challenging spiroquaternary stereocenter has
been installed (cf. 52 and 58). The development of this valuable asymmetric transformation
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highlights the ongoing efforts to devise new and useful techniques toward construction of
important molecules.
Conclusion
The representative synthetic efforts presented herein demonstrate the critical interplay between
target-directed synthesis and the development of novel reaction methodology. Although many
useful asymmetric technologies are currently available, the specific challenges posed by
important natural product and pharmaceutical compounds highlight deficiencies in the current
technology. Envisioning strategies to construct these relevant molecules through means beyond
the current arsenal of enantioselective transformations will facilitate the evolution of both
synthetic planning and reaction development. The symbiotic relationship between total
synthesis and method development can continue to expand the understanding of synthetic
strategy and catalysis on both fundamental and practical levels.
Despite the substantial advances realized to date, significant challenges remain for both multi-
step synthesis and catalysis. In addition to enhancements to efficiency and selectivity, better
reactivity and handling stability are continually required to implement and improve industrial
processes for existing methods. Exceptionally reliable methods will aid in the discovery of new
bioactive compounds through high-throughput combinatorial screening techniques that are
well established in the pharmaceutical industry, but relatively limited by the number of readily
accessible chiral building blocks. Existing methods may be improved by identifying systems
with better functional group tolerances that might obviate the need for protecting and masking
groups. Similarly, known privileged chiral frameworks may be modified to more effectively
control chiral space for especially challenging transformations, a technique conspicuously
successful for Trost's TMM cyclizations.
Creative solutions are required to address specific organic transformations that remain
significant impediments to efficient syntheses, namely: formation of multiple stereocenters
and rings, formation of multiple C–C bonds, generation of vicinal quaternary stereocenters,
and C–H and C–C functionalization reactions. Cyclic structures often present particular
challenges due to the unique strain and steric elements imparted by their connectivity. As a
result, many highly strained or complex polycyclic structures are daunting targets for synthesis.
Finally, the disclosure of new natural product possessing novel structures will serve to identify
new and different challenges for synthetic chemistry and catalysis.
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Figure 1. Selected examples of enantioselective catalysis in total synthesis
Natural products and pharmaceuticals often possess challenging structural features and
functionalities, particularly stereochemical elements. (a) Corey's synthesis of prostaglandin
E2 utilizing an asymmetric Diels–Alder reaction13 and carbonyl reduction.16 Various
industrial applications, including (b) the asymmetric hydrogenation toward α-amino acid
building blocks,19 (c) the asymmetric epoxidation toward Merck's HIV protease inhibitor
Crixivan®,20 and (d) the asymmetric isomerization of allylic amines en route to commodity
chemicals,21 have explored the limits of catalysis and efficiency to minimize cost. The
asymmetric construction of C–C bonds, apparent in (e) the amino acid-catalyzed
intramolecular aldol condensation toward important steroid building blocks,27 and (f) various
enantioselecitive intermolecular aldol reactions toward fragments of the cytostatic agent
phorboxazole B,28 maximize the use of stereochemical information of precious intermediates
through convergency. (Reduced to 45%)
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Figure 2. Asymmetric hydrogenation of β-enamino amides toward Januvia® (8)
The rapid and selective synthesis of β-enamino amide 3 enabled a key rhodium/5-catalyzed
enantioselective hydrogenation under mildly acidic conditions to directly reveal the β-amino
amide in Merck's synthesis of Januvia®, an FDA-approved treatment for type II diabetes.36,
39 DMAP, 4-(N,N-dimethylamino)pyridine; DMA, N,N-dimethylacetamide; PivCl, pivaloyl
chloride; COD, cyclooctadiene. (Reduced to 45%)
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Figure 3. Enantioselective C(sp3)–C(sp3) cross-coupling toward fluvirucinine A1 (17)
Sequential asymmetric C(sp3)–C(sp3) Negishi cross-couplings of racemic allylic chlorides and
alkylzinc reagents catalyzed by nickel/(S,S)-16 enabled the rapid formal synthesis of
Fluvirucinine A1 with excellent enantio- and diastereoselectivity, highlighting a creative
solution to remote stereochemical control in unfunctionalized systems.51 Glyme, 1,2-
dimethoxyethane; DMF, N,N-dimethylformamide. (Reduced to 45%)
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Figure 4. Asymmetric Heck cyclization toward minfiensine (22)
The palladium/23-catalyzed enantioselective intramolecular Heck cyclization of 19 forged the
C(9a) all-carbon quaternary stereocenter, and upon acid-mediated cyclization, the polycyclic
core of minfiensine. The application of this method allowed the diastereoselective preparation
of the remaining stereocenter and completion of the alkaloid.61 PMP, 1,2,2,6,6-
pentamethylpiperidine. (Reduced to 45%)
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Figure 5. Amine-catalyzed indole alkylation toward flustramine B (27)
The enantioselective C(3a) alkylation of tryptamine derivative 24 catalyzed by amine 29, upon
subsequent intramolecular cyclization, provided the pyrroloindoline core of (−)-flustramine B.
This selective cascade process prepared the all-carbon quaternary stereocenter rapidly and
efficiently enabling completion of this K-channel blocker.74 (Reduced to 45%)
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Figure 6. Enantioselective Pictet–Spengler cyclization toward harmicine (35)
Facile prepartion of hydroxylactam 31 facilitated the asymmetric Pictet–Spengler cyclization
catalyzed by thiourea 32. The enantioselective N-acyl iminium ion cyclization enabled rapid
construction of the alkaloid (+)-harmicine following this key transformation.81 TMSCl,
chlorotrimethylsilane; THF, tetrahydrofuran. (Reduced to 45%)
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Figure 7. Asymmetric phase-transfer alkylation toward indacrinone (40)
Merck scientists developed an enantioselective alkaloid salt-catalyzed phase-transfer enolate
alkylation to gain access to indanone 39 with excellent stereoselectivity en route to the diuretic
drug candidate indacrinone.84 (Reduced to 45%)
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Figure 8. Double enantioselective enolate alkylation and the synthesis of cyanthiwigin F (48)
Preparation of a diastereomeric mixture of racemic and meso β-ketoester 42 allowed the
strategic application of the palladium/(S)-23-catalyzed double enantioselective enolate
alkylation to generate both all-carbon quaternary stereocenters of 43 with excellent
stereoselectivity. A subsequent Negishi coupling, ring-closing metathesis, and radical-
mediated aldehyde-olefin cyclization rapidly constructed the tricyclic core of cyanthiwigin F,
completing a synthesis highlighted by several steps that involve the generation of multiple C–
C bonds.87 dmdba, bis(3,5-dimethyoxybenzylidene)acetone; KHMDS, potassium bis
(trimethylsilyl)amide; PhN(Tf)2, phenyl bis(trifluoromethane)sulfonimide; AIBN, 2,2′-azobis
(isobutyronitrile); dppf, 1,1′-bis(diphenylphosphino)ferrocene. (Reduced to 45%)
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Figure 9. Enantioselective trimethylenemethane [3 + 2] cyclization toward marcfortine B (55)
(a) The palladium-catalyzed trimethylenemetane [3 + 2] cyclization of oxindole 50 prepared
cyclopentane 52 in excellent yield. Elaboration to tetracycle 53 facilitated an intramolecular
radical cyclization to synthesize the core of marcfortine B, which was completed in seven
additional steps.95 (b), The recent development of enantioselective palladium-catalyzed TMM
cyclizations with (R,R,R)-59 allows access to spiro-annulated products such as 58 with high
diastereo- and enantioselecitivity.99 The potential application to marcfortine B has not yet
been realized. Boc, tert-butoxycarbonyl; dba, bis(benzylidene)acetone. (Reduced to 45%)
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